Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference40 articles.
1. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison;Capodanno;J Am Coll Cardiol,2018
2. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey;Cao;Eur Heart J,2020
3. Safety and efficacy of P2Y (12) inhibitor monotherapy in patients undergoing percutaneous coronary interventions;Galli;Expert Opin Drug Saf,2020
4. Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35,785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomised controlled trials;Benenati;Eur Heart J Cardiovasc Pharmacother,2020
5. Evolution of coronary stent technology and implications for duration of dual antiplatelet therapy;Moon;Prog Cardiovasc Dis,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect of coronary stent policies on the risk of percutaneous coronary intervention among acute coronary syndrome patients in Shanghai: Real-world evidence;PLOS ONE;2024-04-01
2. Hemostasiological Aspects of PCI: Periprocedural Changes in the Activity of the Platelet Link of Hemocoagulation on the Background of Prior Double Antiplatelet Therapy in Patients with Chronic Coronary Syndrome;Ukrainian Journal of Cardiovascular Surgery;2023-09-28
3. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?;European Journal of Internal Medicine;2023-04
4. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy;European Heart Journal - Cardiovascular Pharmacotherapy;2022-03-30
5. Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients;Journal of Thrombosis and Thrombolysis;2022-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3